Breakdown | |||||
TTM | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
14.24M | 8.90M | 4.25M | 3.38M | 327.30K | 29.45K | Gross Profit |
4.10M | 2.43M | -789.45K | -1.19M | -1.06M | 16.71K | EBIT |
1.19M | -1.19M | -1.77M | -2.54M | -2.15M | -1.91M | EBITDA |
390.96K | 107.19K | -1.23M | -2.04M | -856.03K | -1.87M | Net Income Common Stockholders |
-548.62K | -734.41K | -1.68M | -2.33M | -923.72K | -2.42M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
2.77M | 3.49M | 2.00M | 4.00M | 7.45M | 2.00M | Total Assets |
25.07M | 26.92M | 11.96M | 12.67M | 12.97M | 6.55M | Total Debt |
7.62M | 7.91M | 2.80M | 1.22M | 494.99K | 0.00 | Net Debt |
4.85M | 4.42M | 793.42K | -2.79M | -6.96M | -2.00M | Total Liabilities |
9.78M | 11.42M | 3.80M | 2.98M | 1.10M | 403.02K | Stockholders Equity |
15.29M | 15.49M | 8.17M | 9.69M | 11.87M | 6.15M |
Cash Flow | Free Cash Flow | ||||
1.30M | 470.83K | -1.74M | -3.43M | -2.73M | -1.51M | Operating Cash Flow |
1.54M | 644.44K | -1.34M | -2.12M | -2.45M | -1.49M | Investing Cash Flow |
-3.40M | -3.78M | -435.18K | -1.34M | 1.33M | 257.10K | Financing Cash Flow |
728.13K | 4.62M | -227.25K | 12.87K | 6.57M | 3.11M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
64 Neutral | $4.43B | 12.01 | 5.15% | 249.50% | 3.98% | -11.60% | |
64 Neutral | AU$1.72B | 50.09 | 3.35% | 1.91% | 4.28% | ― | |
58 Neutral | $401.03M | 6.01 | 10.65% | ― | -11.86% | 15.29% | |
54 Neutral | AU$5.09B | ― | -3.14% | 4.24% | -13.30% | -419.73% | |
51 Neutral | $900.75M | 26.09 | 2.26% | ― | 15.11% | ― | |
40 Underperform | AU$29.05M | ― | -4.11% | ― | 217.39% | 50.00% |
Parkway Corporate Limited has announced the issuance of 16,800,940 unquoted performance rights securities, effective May 14, 2025. This move is part of previously announced transactions and is not intended for quotation on the ASX, potentially impacting the company’s equity structure and stakeholder interests.
Parkway Corporate Limited reported a strong quarterly performance with strategic growth in engineering solutions and a focus on safety and performance, highlighted by the renewal of ISO certifications. The company is advancing its Queensland Brine Solutions (QBS) project and has been engaged by a global mining company to evaluate brine technology for a critical minerals project. Parkway is transitioning to profitability, supported by several project awards and a deep project pipeline, and has initiated regular shareholder webinars to enhance communication.
Parkway Corporate Limited has announced a change in its share registry services, transferring responsibilities from Automic Pty Ltd to Xcend Pty Ltd, effective 31 March 2025. This transition to Xcend is expected to enhance the management of shareholder services through a secure online portal, potentially improving stakeholder engagement and operational efficiency.
Parkway Corporate Limited has announced significant progress in its Queensland Brine Solutions (QBS) projects, including the launch of a dedicated website to enhance stakeholder engagement and a growing pipeline of water infrastructure projects. The company is actively working on strategic brine processing projects in Central Queensland, which are anticipated to provide a long-term solution for the CSG industry. Parkway is also negotiating a long-term lease for a Brine Management Complex and has executed a binding term sheet for a Brine Electrolysis Complex. These developments are expected to strengthen Parkway’s competitive advantage and industry positioning, with further disclosures anticipated soon.
Parkway Corporate Limited has released its condensed consolidated half-year financial report for the period ending December 31, 2024. The report includes key financial statements such as the statement of profit or loss, statement of financial position, and statement of cash flows. This release provides stakeholders with insights into the company’s financial health and operational performance over the past six months, which may impact future strategic decisions and market positioning.